Fang CY - Search Results

1

Enhanced production of recombinant coxsackievirus A16 using a serum-free HEK293A suspension culture system for bivalent enterovirus vaccine development.

Chen YA, Shen YS, Fang CY, Chan TT, Wu SR, Wang JR, Wu SC, Liu CC. Chen YA, et al. Among authors: fang cy. Vaccine X. 2024 Sep 19;20:100559. doi: 10.1016/j.jvacx.2024.100559. eCollection 2024 Oct. Vaccine X. 2024. PMID: 39364390 Free PMC article.

2

Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system.

Lien SC, Shen YS, Lin HY, Wu SR, Fang CY, Chen CH, Chen YA, Chong PC, Huang MH, Chow YH, Wang JR, Wu SC, Liu CC. Lien SC, et al. Among authors: fang cy. Virus Res. 2023 May;329:199101. doi: 10.1016/j.virusres.2023.199101. Epub 2023 Mar 24. Virus Res. 2023. PMID: 36958398 Free PMC article.

3

Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.

Fang CY, Liu CC. Fang CY, et al. Expert Rev Vaccines. 2018 Sep;17(9):819-831. doi: 10.1080/14760584.2018.1510326. Epub 2018 Aug 22. Expert Rev Vaccines. 2018. PMID: 30095317 Free article. Review.

4

Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies.

Fang CY, Liu CC. Fang CY, et al. Expert Opin Drug Discov. 2022 Jan;17(1):27-39. doi: 10.1080/17460441.2021.1965987. Epub 2021 Aug 19. Expert Opin Drug Discov. 2022. PMID: 34382876

5

Separation and purification of highly infectious enterovirus A71 particles using a strong anion-exchange column.

Lien SC, Lu CC, Shen YS, Yang YT, Wu SR, Fang CY, Chow YH, Liao CL, Chiang JR, Liu CC. Lien SC, et al. Among authors: fang cy. J Chromatogr A. 2022 Sep 13;1680:463427. doi: 10.1016/j.chroma.2022.463427. Epub 2022 Aug 18. J Chromatogr A. 2022. PMID: 36029731

6

The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage.

Shen YS, Chow YH, Fang CY, Wu SR, Chen CH, Huang MH, Liao CL, Chiang JR, Liu CC. Shen YS, et al. Among authors: fang cy. J Microbiol Immunol Infect. 2023 Dec;56(6):1121-1128. doi: 10.1016/j.jmii.2023.10.006. Epub 2023 Oct 28. J Microbiol Immunol Infect. 2023. PMID: 37919172 Free article.

7

Reactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidine.

Huang SY, Fang CY, Wu CC, Tsai CH, Lin SF, Chen JY. Huang SY, et al. Among authors: fang cy. PLoS One. 2013 Dec 20;8(12):e84919. doi: 10.1371/journal.pone.0084919. eCollection 2013. PLoS One. 2013. PMID: 24376853 Free PMC article.

8

EBV reactivation as a target of luteolin to repress NPC tumorigenesis.

Wu CC, Fang CY, Hsu HY, Chuang HY, Cheng YJ, Chen YJ, Chou SP, Huang SY, Lin SF, Chang Y, Tsai CH, Chen JY. Wu CC, et al. Among authors: fang cy. Oncotarget. 2016 Apr 5;7(14):18999-9017. doi: 10.18632/oncotarget.7967. Oncotarget. 2016. PMID: 26967558 Free PMC article.

9

Exosomal Components and Modulators in Colorectal Cancer: Novel Diagnosis and Prognosis Biomarkers.

Chang YC, Chan MH, Li CH, Fang CY, Hsiao M, Chen CL. Chang YC, et al. Among authors: fang cy. Biomedicines. 2021 Jul 31;9(8):931. doi: 10.3390/biomedicines9080931. Biomedicines. 2021. PMID: 34440135 Free PMC article. Review.

10

Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.

Chiu SH, Wu CC, Fang CY, Yu SL, Hsu HY, Chow YH, Chen JY. Chiu SH, et al. Among authors: fang cy. Oncotarget. 2014 Sep 30;5(18):8583-601. doi: 10.18632/oncotarget.2323. Oncotarget. 2014. PMID: 25261366 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

518 results

Search Page

Filters